Homepage

Stories / NERD Blog
Novartis taps MOOC technology to share chemistry education with the world
Stories / NERD Blog
Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
Stories / NERD Blog
Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.
Stories / NERD Blog
An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Explore the Novartis Institutes for BioMedical Research

Recent Updates

Find stories and insights about our efforts to discover and develop new medicines.